Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
No earnings calls available for this ticker.
At close: 27 April at 16:00:00 GMT-4 ...
As of May 21 at 4:00:00 PM EDT. Market Open. Get top stock picks Research reports are not currently available for TRRI.
Find the latest Alzex Neuropharma Inc. (TRRI) stock quote, history, news and other vital information to help you with your stock trading and investing.
TRRI Company Profile Alzex Neuropharma Inc., a development stage biopharmaceutical company, engages in developing therapeutics for the treatment of Alzheimer's Disease and other neurological diseases.
Alzex Neuropharma Inc. (TRRI) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.
At close: 30 March at 4:00:00 pm GMT-4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results